Department of Health and Human Services September 26, 2007 – Federal Register Recent Federal Regulation Documents
Results 1 - 6 of 6
Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for the addition of a pathogen to the indication for use of tulathromycin, by injection, for the control of respiratory disease in high-risk cattle.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.